Search:
Dave Gosine's Articles in Diseases
Show All
|
Display Category
|
Title
|
Newest
|
Oldest
SGX Pharmaceuticals Announces Strategic Collaboration To Develop And Commercialize BCR-ABL Inhibitor
SGX Pharmaceuticals, Inc. (NASDAQ:SGXP) has announced that it has entered into a license and collaboration agreement with Novartis focused on the development and commercialization of BCR-ABL inhibitors for the treatment of drug resistant Chronic Myelogenous Leukemia (CML).
St. Jude Unlocks Mystery of Very Aggressive Leukemia
Loss of Arf gene in acute lymphoblastic leukemia makes some forms of this cancer resistant to treatment with imatinib, but blocking JAK kinases can restore the sensitivity of cells to this drug.
More Info
.
Popular Articles
Contact Us
Privacy Policy
Terms of Service
Article RSS Feeds
Mortgage Listing
Health Listing
Foreclosure Listing
Insurance Listing
Lasik Listing
Spyware Listing
Personal Finance
Baby News
Chrome Plugins
Google Chrome Forums
Domain Forum
Trucks For Sale
Design by
SEO
Info:
SEO Forum
Providing Articles on everything from Credit
